(Q37890024)

English

Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials

scientific article published on July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

0 references

1 reference

Europe PubMed Central

Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

0 references

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

budesonide/formoterol

1 reference

based on heuristic

inferred from title

author name string

D M G Halpin

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

J Gray

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

S J Edwards

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

J Morais

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

D Singh

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

764-774

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Indirect comparisons of treatments based on systematic reviews of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Methods for therapeutic trials in COPD: lessons from the TORCH trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02685.X

21 January 2018

Identifiers

10.1111/J.1742-1241.2011.02685.X

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37890024&oldid=1754706429"